1. A patent review of selective CDK9 inhibitors in treating cancer
   Tizhi Wu et al, 2023, Expert Opinion on Therapeutic Patents CrossRef
2. Editorial for “Impact of Regorafenib on Endothelial Transdifferentiation of Glioblastoma Stem-like Cells”
   Madhukrishna Kolothara Unnikrishnan et al, 2023, Cancers CrossRef
3. Brachytherapy is an effective and safe salvage option for re-irradiation in recurrent glioblastoma (rGBM): a systematic review
   Xiaoyong Xiang et al, 2023, Radiotherapy and Oncology CrossRef
4. Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapies
   Alberto Visioli et al, 2023, J Exp Clin Cancer Res CrossRef
5. Molecular mechanisms of tumour development in glioblastoma: an emerging role for the circadian clock
   Nina Nelson et al, 2024, npj Precis. Onc. CrossRef
6. Principles in the Management of Glioblastoma
   Domingos Roda et al, 2024, Genes CrossRef
7. Decreased LTBP2 expression inhibits proliferation and migration of glioma
   Yonghui Zhang et al, 2024, Mol. Cell. Toxicol. CrossRef
8. A preliminary study on the impact of nutrient stress induction on drug cytotoxicity in glioblastoma cells and fibroblasts
   Siti Nazihahasma Hassan et al, 2024, Futur J Pharm Sci CrossRef
9. null
   Asokan Madeshwaran et al, 2024 CrossRef